Century Therapeutics, Inc.
IPSC
$2.43
$0.135.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 44.32% | -5.80% | -142.50% | 312.24% | -15.53% |
| Total Depreciation and Amortization | 13.45% | -2.25% | -0.62% | -2.92% | 0.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -155.51% | 165.50% | 35.62% | -73.02% | 182.90% |
| Change in Net Operating Assets | 497.23% | -12.93% | 99.39% | -6,450.38% | 165.95% |
| Cash from Operations | 37.16% | 7.28% | 20.31% | -42.93% | 14.50% |
| Capital Expenditure | 171.28% | 38.49% | 33.26% | -208.44% | -119.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -200.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.63% | -24.32% | 15.67% | -7.72% | -19.79% |
| Cash from Investing | -9.36% | -24.18% | 16.50% | -8.74% | -21.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -100.00% | 119.93% | -320.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 794.09% | -118.46% | 175.26% | -213.70% | -48.11% |